What to do after a missed dosage of Mounjaro

What the prescribing guidance actually says about missed Mounjaro doses

The Mounjaro Summary of Product Characteristics, published on the Electronic Medicines Compendium, is the definitive clinical reference for this question. It draws a single, clear line: four days. If you discover the miss within the first three days of your intended injection day, give the dose immediately and then keep your regular weekly day going forward. If the fourth day has already passed and your next injection is due within 96 hours, leave the missed dose entirely and pick up the routine from there.

One thing the guidance is unambiguous about: do not double up. Taking two doses close together will not accelerate results, but it does raise the likelihood of nausea, vomiting and other gastrointestinal effects that patients already find the trickiest part of early treatment. The one-week gap between doses exists for a reason rooted in tirzepatide's pharmacology, not habit.

If you're unsure where you are in your schedule, or you've recently been titrated to a new strength, it's worth reading through the guidance on what to do when you've missed a Mounjaro dose before reaching for the pen, and if you want to make the most of every cartridge, our guide on how to break a Mounjaro pen for the golden dose is also worth a look.

Why one missed week rarely derails progress, but patterns do

Tirzepatide has a relatively long plasma half-life of roughly five days. In practical terms, a single missed injection does not cause the medicine to vanish from your system overnight. Clinical pharmacology data from the SURMOUNT programme (which studied tirzepatide in thousands of adults with obesity) showed the drug's effects on appetite and gastric emptying build gradually over weeks, not days. One missed dose sits within that biological buffer.

That said, the buffer is not a licence for repeated gaps. Consistent weekly dosing is what produces the steady-state concentrations that underpin the results seen in clinical trials. Patients who miss doses frequently may find that GI side effects re-emerge when they restart, almost as though the body needs to re-acclimatise. If supply disruption is the reason you've missed a dose, the detail on missing a full week of Mounjaro covers what to expect and how to plan ahead.

It is also worth noting that if you are several weeks into a titration and you've missed two or more doses in a row, your prescriber may choose to step back your dose rather than continue at the current strength. That decision belongs to the clinician, not the Patient Information Leaflet, so reach out before assuming you simply resume. Our dedicated page on what to do after a missed tirzepatide dose can help you think through exactly what to tell them.

Longer gaps: missed doses stretching to two or three weeks

A gap of two or three weeks is a different situation. After roughly two weeks without tirzepatide, systemic concentrations will have fallen substantially. Restarting at the dose you were on when you stopped carries a meaningful risk of nausea and other gastrointestinal effects returning, as your system adjusts again from a lower baseline.

Prescribers will typically assess whether continuing at the same strength is appropriate or whether a temporary step back helps you re-establish tolerance. This isn't a setback, it's clinical caution, and it's the same logic that leads to the gradual titration schedule in the first place. If you've been away from your pen for three weeks or more, the page on missing three weeks of Mounjaro goes into more detail. And if you're waiting on a delayed delivery and cost is adding to the stress, it's worth looking at how Mounjaro pricing works in the UK so you understand what a continuous supply actually involves.

We hear from patients occasionally who feel embarrassed about a long gap, perhaps they were ill, travelling, or simply struggling. That's understandable. The right move is honesty with your prescriber, not silence. A clinical reassessment is a straightforward conversation, not a judgement.

When to contact your prescriber rather than rely on the four-day rule

The four-day rule covers the straightforward case. Several situations sit outside it and call for clinical input rather than self-management. These include: missing doses because of persistent side effects rather than forgetting; uncertainty about where you are after a recent dose increase; gaps caused by pen malfunction rather than scheduling; and any situation involving a change in your health that makes you wonder whether to continue at all.

Mounjaro is a prescription-only medicine subject to ongoing clinical review, that's not a formality, it's the point. At nume, a named prescriber re-reviews your case before each repeat order, which is precisely the kind of checkpoint that catches a dose-management question before it becomes a problem. If you'd like to understand more about what our prescribers cover, our clinical team explains how oversight works at our pharmacy. The NHS patient information for tirzepatide is also worth bookmarking as a plain-English reference for ongoing questions.

For anyone starting treatment or wondering whether tirzepatide might be right for them, check your eligibility with a free consultation, our prescribers can talk through dosing schedules alongside everything else.